Skip to main content
. 2015 Feb 18;35(7):3155–3173. doi: 10.1523/JNEUROSCI.0586-14.2015

Table 1.

Plasmids used in this study

Plasmid name Cloning technique Cloning sites Feature Tags Source
pIRES2-EGFP Starting vector Clontech
pIRES2-EGFP-CHMP2B WT In-Fusion (Clontech) XhoI, XhoI RNAi res. C-terminal FLAG This study
pBI-CMV3 Starting vector Clontech
pBI-CMV3-CHMP2B WT In-Fusion (Clontech) BamHI, HindIII RNAi res. This study
pBI-CMV3-CHMP2B R19/22/26A In-Fusion (Clontech) BamHI, HindIII RNAi res. This study
pBI-CMV3-CHMP2B L4D/F5D In-Fusion (Clontech) BamHI, HindIII RNAi res. This study
pBI-CMV3-CHMP2B L207D/L210D In-Fusion (Clontech) BamHI, HindIII RNAi res. This study
pSuper-mCherry Starting vector Belly et al., 2010
pSuper-mCherry shRNA vs CHMP2B Standard ligation HindIII, BglII Belly et al., 2010
pSuper-mCherry shRNA vs GFP Standard ligation HindIII, BglII This study
pCDNA3.1-CHMP2B WT Topo (Invitrogen) C-terminal HA This study
pCDNA3.1-CHMP2B R19/22/26A Topo (Invitrogen) C-terminal HA This study
pCDNA3.1-CHMP4B Topo (Invitrogen) C-terminal FLAG Bodon et al., 2011

The cloning technique used to construct each plasmid and, if applicable, the associated kit supplier are indicated. RNAi res. Indicates the encoded mRNA is resistant to RNAi by the Chmp2b shRNA.